Biopharmaceuticals
News Release - September 4, 2008
Amgen and Wyeth Statement on the FDA Safety Announcement Regarding Tumor Necrosis Factor (TNF) Blockers
Source: Amgen
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.